High throughput screening of natural products for anti-mitotic effects in MDA-MB-231 human breast carcinoma cells

Phytotherapy Research

Volumn 28, Issue 6, 2014, Pages 856-867

  Mazzio, E ^a   Badisa, R ^a   Mack, N ^a   Deiab, S ^a   Soliman, K F A ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

cancer; herbs; high throughput; plant; screening

Indexed keywords

ANTINEOPLASTIC AGENT; BRUCEA JAVANICA EXTRACT; CEDAR LEAF OIL; COLLINSONIA CANADENSIS EXTRACT; DIOSCOREA VILLOSA EXTRACT; FUCUS VESICULOSUS EXTRACT; HAMAMELIS VIRGINIANA EXTRACT; INULA HELENIUM EXTRACT; LITHOSPERMUM CANESCENS EXTRACT; MELAPHIS CHINENSIS EXTRACT; MELIA TOOSENDAN EXTRACT; NATURAL PRODUCT; PACLITAXEL; PHORADENDRON FLAVESCENS EXTRACT; PLANT EXTRACT; PODOPHYLLUM PELTATUM EXTRACT; POLYGALA TENUIFOLIA EXTRACT; PULSATILLA CHINENSIS EXTRACT; RUBIA TINCTORUM EXTRACT; SPERANSKIA TUBERCULATA EXTRACT; TERMINALIA ARJUNA EXTRACT; TRILLIUM PENDULUM EXTRACT; UNCLASSIFIED DRUG; WATER;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOMA; BRUCEA JAVANICA; CANCER INHIBITION; COLLINSONIA CANADENSIS; CONTROLLED STUDY; CYTOTOXICITY TEST; DIOSCOREA VILLOSA; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; ELECAMPANE; FUCUS VESICULOSUS; G2 PHASE CELL CYCLE CHECKPOINT; HAMAMELIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; LITHOSPERMUM CANESCENS; MEDICINAL PLANT; MELAPHIS CHINENSIS; MELIA TOOSENDAN; MICROARRAY ANALYSIS; PHORADENDRON FLAVESCENS; PLANT ROOT; PODOPHYLLUM PELTATUM; POLYGALA TENUIFOLIA; PULSATILLA CHINENSIS; RUBIA TINCTORUM; SPERANSKIA TUBERCULATA; TERMINALIA ARJUNA; THUJA; TRILLIUM PENDULUM;

CANCER; HERBS; HIGH THROUGHPUT; PLANT; SCREENING;

ANGIOSPERMS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MITOSIS; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 84902202960     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5065     Document Type: Article

References (72)

1. Alonso-Castro AJ, Juarez-Vazquez Mdel C, Dominguez F, et al,. 2012. The antitumoral effect of the American mistletoe Phoradendron serotinum (Raf.) M.C. Johnst. (Viscaceae) is associated with the release of immunity-related cytokines. J Ethnopharmacol 142: 857-64.
2. Ardizzoni A,. 1995. Camptothecin analogues in the treatment of non-small cell lung cancer. Lung Cancer 12 Suppl 1: S177-85.
3. Bang SC, Lee JH, Song GY, Kim DH, Yoon MY, Ahn BZ,. 2005. Antitumor activity of Pulsatilla koreana saponins and their structure-activity relationship. Chem Pharm Bull (Tokyo) 53: 1451-4.
4. Bar-Sela G, Wollner M, Hammer L, Agbarya A, Dudnik E, Haim N,. 2013. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study. Eur J Cancer 49: 1058-64.
5. Binder S,. 2013. Evolution of taxanes in the treatment of metastatic breast cancer. Clin J Oncol Nurs 17: 9-14.
6. Biswas R, Mandal SK, Dutta S, Bhattacharyya SS, Boujedaini N, Khuda-Bukhsh AR,. 2011. Thujone-rich fraction of Thuja occidentalis demonstrates major anti-cancer potentials: evidences from in vitro studies on A375 cells. Evid Based Complement Alternat Med 2011: 568148.
7. Botta B, Delle Monache G, Misiti D, Vitali A, Zappia G,. 2001. Aryltetralin lignans: chemistry, pharmacology and biotransformations. Curr Med Chem 8: 1363-81.
8. Brandenberger M, Simoes-Wust AP, Rostock M, Rist L, Saller R,. 2012. An exploratory study on the quality of life and individual coping of cancer patients during mistletoe therapy. Integr Cancer Ther 11: 90-100.
9. Chacko AD, McDade SS, Chanduloy S, et al,. 2012. Expression of the SEPT9-i4 isoform confers resistance to microtubule-interacting drugs. Cell Oncol (Dordr) 35: 85-93.
10. Choi JH, Lyu SY, Lee HJ, Jung J, Park WB, Kim GJ,. 2012. Korean mistletoe lectin regulates self-renewal of placenta-derived mesenchymal stem cells via autophagic mechanisms. Cell Prolif 45: 420-9.
11. Damayanthi Y, Lown JW,. 1998. Podophyllotoxins: current status and recent developments. Curr Med Chem 5: 205-52.
12. Day TW, Wu CH, Safa AR,. 2009. Etoposide induces protein kinase Cdelta- and caspase-3-dependent apoptosis in neuroblastoma cancer cells. Mol Pharmacol 76: 632-40.
13. Eisenbraun J, Scheer R, Kroz M, Schad F, Huber R,. 2011. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract. Phytomedicine 18: 151-7.
14. English DP, Roque DM, Santin AD,. 2013. Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents? Expert Rev Anticancer Ther 13: 63-74.
15. Evans SM, Casartelli A, Herreros E, et al,. 2001. Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential. Toxicol In Vitro 15: 579-84.
16. Fitzgerald DP, Emerson DL, Qian Y, et al,. 2012. TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells. Mol Cancer Ther 11: 1959-67.
17. Foa R, Norton L, Seidman AD,. 1994. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. Int J Clin Lab Res 24: 6-14.
18. Froidevaux-Klipfel L, Poirier F, Boursier C, et al,. 2011. Modulation of septin and molecular motor recruitment in the microtubule environment of the Taxol-resistant human breast cancer cell line MDA-MB-231. Proteomics 11: 3877-86.
19. Fujikawa-Yamamoto K, Ota T, Miyagoshi M, Yamagishi H,. 2012. Effects of etoposide on the proliferation of hexaploid H1 (ES) cells. Hum Cell 25: 45-50.
20. Gao H, Lamusta J, Zhang WF, et al,. 2011. Tumor cell selective cytotoxicity and apoptosis induction by an herbal preparation from Brucea javanica. N Am J Med Sci (Boston) 4: 62-6.
21. Graeowska S, Ross B,. 1976. [ Analysis of causes and assessment of therapeutic results in 30 cases of temporomandibular joint diseases ]. Czas Stomatol 29: 1111-7.
22. Gu Q, Xing JZ, Huang M, Zhang X, Chen J,. 2013. Nanoformulation of paclitaxel to enhance cancer therapy. J Biomater Appl 28: 298-307.
23. Guruvayoorappan C, Kuttan G,. 2008a. Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol 30: 711-27.
24. Guruvayoorappan C, Kuttan G,. 2008b. Inhibition of tumor specific angiogenesis by amentoflavone. Biochemistry (Mosc) 73: 209-18.
25. Hong SW, Jung KH, Lee HS, et al,. 2012a. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway. Cancer Sci 103: 1929-37.
26. Hong SW, Jung KH, Lee HS, et al,. 2012b. Apoptotic and anti-angiogenic effects of Pulsatilla koreana extract on hepatocellular carcinoma. Int J Oncol 40: 452-60.
27. Jurin M, Zarkovic N, Borovic S, Kissel D,. 1997. Viscum album L. preparation Isorel modifies the immune response in normal and in tumour-bearing mice. Anticancer Drugs 8 (1): S27-31.
28. Kim KC, Yook JH, Eisenbraun J, Kim BS, Huber R,. 2012. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma-a randomized, controlled pilot study. BMC Complement Altern Med 12: 172.
29. Kim Y, Bang SC, Lee JH, Ahn BZ,. 2004. Pulsatilla saponin D: the antitumor principle from Pulsatilla koreana. Arch Pharm Res 27: 915-8.
30. Lata H, Mizuno CS, Moraes RM,. 2009. The role of biotechnology in the production of the anticancer compound podophyllotoxin. Methods Mol Biol 547: 387-402.
31. Lau ST, Lin ZX, Liao Y, Zhao M, Cheng CH, Leung PS,. 2009. Bruceine D induces apoptosis in pancreatic adenocarcinoma cell line PANC-1 through the activation of p38-mitogen activated protein kinase. Cancer Lett 281: 42-52.
32. Lee S, Kim H, Kang JW, et al,. 2011. The biflavonoid amentoflavone induces apoptosis via suppressing E7 expression, cell cycle arrest at sub-G(1) phase, and mitochondria-emanated intrinsic pathways in human cervical cancer cells. J Med Food 14: 808-16.
33. Leiter J, Abbott BJ, Bourke AR, Fitzgerald DB, Schepartz SA,. 1962. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. IX. Plant extracts. Cancer Res 22: 609-738.
34. Leiter J, Bourke AR, Schepartz SA, Abbott BJ, Fitzgerald DB,. 1961. Screening data from the cancer chemotherapy National Service Center screening laboratories. VI. Plant extracts. Cancer Res 21 (3) Pt 2: 93-153.
35. Li C, Zhang CZ, Hu FD, Shi JG,. 2000. [ Chemical constituents from Speranskia tuberculata (Bge.) Baill ]. Zhongguo Zhong Yao Za Zhi 25: 291-2.
36. Liu L, Lin ZX, Leung PS, Chen LH, Zhao M, Liang J,. 2012. Involvement of the mitochondrial pathway in bruceine D-induced apoptosis in Capan-2 human pancreatic adenocarcinoma cells. Int J Mol Med 30: 93-9.
37. Liu S, Yamauchi H,. 2010. Etoposide induces growth arrest and disrupts androgen receptor signaling in prostate cancer cells. Oncol Rep 23: 165-70.
38. Mantle D, Lennard TW, Pickering AT,. 2000. Therapeutic applications of medicinal plants in the treatment of breast cancer: a review of their pharmacology, efficacy and tolerability. Adverse Drug React Toxicol Rev 19: 223-40.
39. Matthes H, Friedel WE, Bock PR, Zanker KS,. 2010. Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer. Curr Mol Med 10: 430-9.
40. Melzer J, Iten F, Hostanska K, Saller R,. 2009. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review. Forsch Komplementmed 16: 217-26.
41. Murray S, Briasoulis E, Linardou H, Bafaloukos D, Papadimitriou C,. 2012. Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies. Cancer Treat Rev 38: 890-903.
42. Naser B, Bodinet C, Tegtmeier M, Lindequist U,. 2005. Thuja occidentalis (Arbor vitae): a review of its pharmaceutical, pharmacological and clinical properties. Evid Based Complement Alternat Med 2: 69-78.
43. Noble RL,. 1990. The discovery of the vinca alkaloids - chemotherapeutic agents against cancer. Biochem Cell Biol 68: 1344-51.
44. Ojeswi BK, Khoobchandani M, Hazra DK, Srivastava MM,. 2010. Protective effect of Thuja occidentalis against DMBA-induced breast cancer with reference to oxidative stress. Hum Exp Toxicol 29: 369-75.
45. Ostermann T, Raak C, Bussing A,. 2009. Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review. BMC Cancer 9: 451.
46. Pan L, Chin YW, Chai HB, Ninh TN, Soejarto DD, Kinghorn AD,. 2009. Bioactivity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam. Bioorg Med Chem 17: 2219-24.
47. Panigrahy D, Kaipainen A, Butterfield CE, et al,. 2010. Inhibition of tumor angiogenesis by oral etoposide. Exp Ther Med 1: 739-46.
48. Park BH, Jung KH, Son MK, et al,. 2012. Antitumor activity of Pulsatilla koreana extract in anaplastic thyroid cancer via apoptosis and anti-angiogenesis. Mol Med Rep 7: 26-30.
49. Pei JS, Liu CC, Hsu YN, et al,. 2012. Amentoflavone induces cell-cycle arrest and apoptosis in MCF-7 human breast cancer cells via mitochondria- dependent pathway. In Vivo 26: 963-70.
50. Podlech O, Harter PN, Mittelbronn M, Poschel S, Naumann U,. 2012. Fermented mistletoe extract as a multimodal antitumoral agent in gliomas. Evid Based Complement Alternat Med 2012: 501796.
51. Ram VJ, Kumari S,. 2001. Natural products of plant origin as anticancer agents. Drug News Perspect 14: 465-82.
52. Salzer G, Havelec L,. 1978. [ Prevention of recurrence of bronchial carcinomas after surgery by means of the mistletoe extract Iscador. Results of a clinical study from 1969-1971 ]. Onkologie 1: 264-7.
53. Schacter L,. 1996. Etoposide phosphate: what, why, where, and how? Semin Oncol 23: 1-7.
54. Shi JG, Wang HQ, Wang M, Yang YC, Hu WY, Zhou GX,. 2000. Polyoxygenated bipyridine, pyrrolylpyridine, and bipyrrole alkaloids from Speranskia tuberculata. J Nat Prod 63: 782-6.
55. Sinkule JA,. 1984. Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent. Pharmacotherapy 4: 61-73.
56. Son MK, Jung KH, Hong SW, et al,. 2013. SB365, Pulsatilla saponin D suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the AKT/mTOR signalling pathway. Food Chem 136: 26-33.
57. Tasyriq M, Najmuldeen IA, In LL, Mohamad K, Awang K, Hasima N,. 2012. 7alpha-Hydroxy-beta-Sitosterol from Chisocheton tomentosus induces apoptosis via dysregulation of cellular Bax/Bcl-2 ratio and cell cycle arrest by downregulating ERK1/2 activation. Evid Based Complement Alternat Med 2012: 765316.
58. Urquhart LM,. 2013. Taxanes as a first-line systemic treatment in metastatic breast cancer. Clin J Oncol Nurs 17: 15-21.
59. Vogelzang NJ, Raghavan D, Kennedy BJ,. 1982. VP-16-213 (etoposide): the mandrake root from Issyk-Kul. Am J Med 72: 136-44.
60. Wang L, Yang YJ, Chen SH, Ge XR, Xu CJ, Gui SQ,. 2006. [ Effects of beta-sitosterol on microtubular systems in cervical cancer cells ]. Zhonghua Yi Xue Za Zhi 86: 2771-5.
61. Wang Q, Wang M, He X, et al,. 2012. [ Meta-analysis on treatment of non-small cell lung cancer with brucea javanica oil emulsion in combination with platinum-contained first-line chemotherapy ]. Zhongguo Zhong Yao Za Zhi 37: 2022-9.
62. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT,. 1971. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-7.
63. Xu J, Liu M, Xia Z,. 2013. Will the Europe union's traditional herbal medicinal products directive (Directive 2004/24/EC) be against traditional Chinese medicine in EU market? J Evid Based Med 6: 104-8.
64. Xu QM, Shu Z, He WJ, et al,. 2012. Antitumor activity of Pulsatilla chinensis (Bunge) Regel saponins in human liver tumor 7402 cells in vitro and in vivo. Phytomedicine 19: 293-300.
65. Yang DZ, Yin XX, Ong CN, Tang DQ,. 2013a. Multidimensional information-based HPLC technologies to evaluate traditional chinese medicine. J Chromatogr Sci 51: 716-25.
66. Yang F, Yu XH, Qiao F, et al,. 2013b. Formulation and characterization of Brucea javanica oil microemulsion for improving safety. Drug Dev Ind Pharm.
67. Yared JA, Tkaczuk KH,. 2012. Update on taxane development: new analogs and new formulations. Drug Des Devel Ther 6: 371-84.
68. Zhang K, Li Y, Zhang ZR, Guan WH, Pu YC,. 2013. [ Chemoinformatics study on antibacterial activity of traditional Chinese medicine compounds ]. Zhongguo Zhong Yao Za Zhi 38: 777-80.
69. Zhao M, Lau ST, Leung PS, Che CT, Lin ZX,. 2011. Seven quassinoids from Fructus Bruceae with cytotoxic effects on pancreatic adenocarcinoma cell lines. Phytother Res 25: 1796-800.
70. Zhao W, Song Y, Xu B, Zhan Q,. 2012. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel. Cancer Biol Ther 13: 156-63.
71. Zheng Y, Zhou F, Wu X, et al,. 2010. 23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo. J Ethnopharmacol 128: 615-22.
72. Zhou J, Zhu J, Chen M, et al,. 2013. Logical thinking in pattern differentiation of traditional Chinese medicine. J Tradit Chin Med 33: 137-40.